DNTH vs IP · rev $6.2M vs P/E 43, $26.62B cap
Dianthus Therapeutics Inc. (DNTH) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
IP does not have a complete income-statement cache yet.
DNTH currently screens at market cap $4.40B. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the DNTH and IP stock pages for the full models.
Not investment advice.